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Abstract 
Introduction: Nowadays, it is indicated that miRNA was anomaly expressed in tumour. Previous studies have shown that miRNAs can 
regulate the proliferation, invasion, and migration of cancer cell-related processes. Meanwhile, current investigations show that RAB23 
also plays an important role in cancer cell-related processes. But the potential mechanism remains unclear.
Material and methods: SW579 cells were selected and transfected with miR-597-3p mimics. Then the expression of miR-597-3p and RAB23 
were measured by quantitative real-time polymerase chain reaction (PCR) and western blotting, respectively. Subsequently, the abilities 
of proliferation, invasion, and migration of SW579 cells were researched. For further study, the Luciferase reporter assay proved that 
miR-597-3p could target the expression of RAB23, and the proteins of invasion and migration were also measured to clear the mechanism. 
Results: After being transfected with miR-597-3p mimics, the expression of miR-597-3p was remarkably increased and RAB23 was signifi-
cantly decreased. The abilities of proliferation, invasion, and migration also decreased significantly. The miRTarase Database predicated 
and Luciferase reporter assay proved that RAB23 was the target gene of miR-597-3p. The expression of matrix metalloproteinase (MMP)-2, 
MMP-9, and N-cadherin was down-regulated, and the expression of E-cadherin was up-regulated. 
Conclusion: miR-597-3p could reduce the proliferation, invasion and migration abilities of SW579 cells, which may be related to the tar-
geted inhibition of RAB23 expression and down-regulation of the expression levels of MMP-2, MMP-9 and N-cadherin proteins of SW579 
cells. (Endokrynol Pol 2021; 72 (1): 22–28)
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Introduction
Thyroid carcinoma (TC) is an aggressive malignancy, 
which originates from parafollicular C cells or follicular 
thyroid [1, 2]. In a recent study, the global mortality rates 
and incremental incidence of TC in patients were shown 
to have increased significantly; in addition, about 20% 
of TC patients develop regional or local recurrences and 
about 15% develop distant metastases. Also, despite tra-
ditional surgery such as radioiodine therapy or surgical 
for TC patients, in most cases it is an incurable disease 
[3, 4]. Thyroid squamous cell carcinoma is a relatively 
rare malignancy, constituting < 1% of all TCs, which 
has a low incidence, high degree of malignancy, and 
poor prognosis [5]. More importantly, the abilities of 
cell proliferation, migration and invasion are the key 
factors leading to poor prognosis and low survival 
rate of thyroid squamous cell carcinoma. MicroRNAs 
(miRNAs), a class of noncoding and small RNAs, play 
a critical role in gene expression by targeting binding 
of the 3’-untranslated region, and thus could regulate 
cellular biological processes such as cell growth, cycle, 
and apoptosis [6, 7]. Recently, more and more miRNAs 
have been found to be involved in the development of 
tumours and effected the metastasis of tumours [8]. In 
thyroid carcinoma, researchers found that the expres-
sion of miR-577 was significantly down-regulated in TC 
tissue and TC-1 cell lines. Up-regulating the expression 
of miR-577 and targeting the supression of SphK2 could 
inhibit the proliferation, invasion, and migration abili-
ties of TC-1 cell lines in vitro [9]. In addition, miR-582-5p 
significantly down-regulated in the salivary adenoid 
cystic carcinoma and significantly influenced the pro-
liferation, invasion, and migration abilities of salivary 
adenoid cystic carcinoma cells by targeting FOXC1 [10]. 
RAB23, a class of Ras-related small GTPase family, was 
first extracted from the brain, and subsequently the role 
of RAB23 was reported in multiple types of tumour and 
was demonstrated to be involved in the development 
and occurrence of lung cancer, liver cancer, gastric 
cancer, and breast cancer, as well as being closely re-
lated to cancer progression [11, 12]. The study showed 
that miR-338-3p bound directly to the 3’-untranslated 
region of RAB23 and was negatively correlated with 
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 — miR-597-3p: 
• F: 5’-ACACTCCAGGTCGGGTGGT-3’
• R: 5’-ATTGGAACGATACAGAGAAGATT-3’
 — U6: 
• F: 5’-TGGTGTCGTGGAGTCG-3’
• R: 5’-GGAACGCTTCACGAATTTG-3’. 
Western blotting assay
The SW579 cells with transfected were lysed by RIPA buffer, 
then the total protein was extracted from the cell lysates and the 
concentration was quantified by BCA protein analysis kit. The 
target proteins were separated by 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE), and proteins were 
transferred onto polyvinylidene fluoride (PVDF) membranes. After 
incubating for 1 h, they were blocked by 5% skimmed milk. The 
monoclonal rabbit-anti-human primary antibodies (dilution 1:100) 
and b-actin as an internal reference were added, and incubated 
at 4°C for 24 h. Next, the membranes were incubated with goat 
anti-rabbit horseradish peroxidase (HRP)-conjugated secondary 
antibody at 25°C for 2 h. Finally, the greyscale images of protein 
were analysed with Gel-Pro Analyzer 4.0.
Cell counting kit 8 (CCK-8) assay to evaluate 
the cell viabilities
The transfected SW579 cells were suspended by FBS-free DMEM 
medium and seeded into 96-well plates at a density of 8 × 103 cells/
/well. The DMEM medium was abandoned and 180 µL DMEM, 
20 µL CCK-8 was added to each well after culturing for 24 h. The 
supernatant was removed after 2 h, and then the absorbance value 
at 450 nm wavelength was measured by microplate reader; mean-
while, 10% of CCK-8 were regarded as blanks. All experiments were 
repeated three times and measured three times; the final results 
were obtained by calculating the average of all results.
Cell invasion and migration assays
The invasion abilities of SW579 cells were estimated by Transwell 
chamber assay. SW579 cells were seeded into the upper chamber, 
which was covered with 50 µL Matrigel Basement Membrane 
Matric (2 mg/mL) and 200 µL FBS-free DMEM medium was added. 
Meanwhile, the 600 µL DMEM with 10% FBS was added into the 
lower chamber. Subsequently, after incubation at 37°C for 24 h, the 
supernatant was abandoned and the SW579 cells remaining in the 
upper chamber were removed using cotton swabs. Invaded cells 
were fixed with methanol for 15 min and subsequently stained 
with 0.1% crystal violet. The migration abilities of SW579 cells were 
estimated by following the aforementioned method, except for the 
lack of Matrigel basement membrane matric. All experiments were 
carried out in triplicate.
Luciferase reporter assay
The potential target genes of miR-335-5p were predicted by the 
miRTarase Database. In order to confirm the sequence of RAB23 
3’-UTR containing the miR-597-3p binding region, the sequence was 
cloned into pGL3 Luciferase reporter vector. The potential miR-597-3p 
binding sites were mutated. The wild type (wt) RAB23 3’-UTR vec-
tor or mutant (mt) RAB23 3’-UTR vector and miR-597-3p mimics 
were co-transfected into SW579 cells by using the LipofectamineTM 
2000 method. Luciferase activity was detected by dual-luciferase 
reporter assay kit.
Statistical analysis
All data were assessed by SPSS software 22.0 (Chicago, USA) and 
were expressed as means ± standard deviation (SD). Paired t test 
was used for within group and one-way ANOVA for between group 
comparisons; p < 0.05 was considered to indicate a statistically 
significant difference.
RAB23 expression, and then suppressed prostate cancer 
growth in vivo, as well as cell proliferation, invasion, 
and migration [13]. Other reports also proved that 
RAB23 correlated with cancer progression; in ovarian 
cancer, the high expression of RAB23 was associated 
with a reduced disease-free survival time and overall 
survival. Subsequently, RAB23 was a target to inhibit 
drug resistance and improve the prognosis of patients 
with ovarian cancer [14]. However, as far as we know, 
the role of miR-597-3p in thyroid carcinoma and its 
relationship with RAB23 has not yet been reported. In 
the present study, the expression of miR-597-3p was 
up-regulated, and then the abilities of proliferation, 
invasion, and migration and the expression of RAB23 
were measured in SW579 cells, which were derived 
from squamous carcinoma. 
Material and methods
Material
Dulbecco’s modified Eagle’s medium (DMEM) and foetal bovine 
serum (FBS) were purchased from Solarbio (Bei Jing, china). MiR-
597-3p mimics and miR-597-3p NC were provided by Ribobio 
Biotechnology Co. (Guangzhou, China). Matrix metalloproteinase 
(MMP)-2, MMP-9, N-cadherin, E-cadherin, b-actin, and IgG-HRP 
antibody were purchased from Solarbio Biotechnology Co. (Bei Jing, 
China). RAB23 antibody was purchased from Heng Fei Biotechnol-
ogy Co. (Shang Hai, China). ProFlex™ polymerase chain reaction 
(PCR) system was manufactured by Thermo Fisher company in 
USA. GelDoc XR+ Gel imager was manufactured by BIO-RAD 
company in USA.
Cell culture
The human thyroid cancer cell line (SW579) was purchased from 
the Shanghai Institutes for Biological Sciences, Chinese Academy 
of Sciences (Shanghai, China). The cells were cultured in DMEM, 
which was supplemented with 10% FBS, 100 µM streptomycin, 
and 100 µM penicillin and placed in an incubator at 37°C, 5% CO2, 
and saturated humidity. The DMEM medium was updated every 
two days, and the cells were passaged by trypsin digestion when 
the cell density reached 90% confluence.
Cell transfection
The SW579 cells were collected and suspended by FBS-free DMEM 
medium. 1 × 105 cells/mL were seeded in 24-well plates and cul-
tured overnight. The SW579 cells were divided into three groups: 
(1) miR-597-3p mimic group (transfected with a miR-597-3p mimic 
sequence); (2) miR-597-3p NC group (transfected with a scrambled 
sequence); and (3) control group (no sequence transfected). The cells 
were transfected by Lipofectamine 2000 for 5 h, and the DMEM 
medium was updated after transfecting.
Quantitative real-time PCR
The total RNA of SW579 cells were isolated by TRIzol reagent. 
cDNA was synthesised by a PrimeScript Reverse Transcriptase kit. 
The relative expression of miR-597-3p was analysed by quantita-
tive real-time PCR apparatus. Reaction system: 0.5 µL forward and 
reverse sequence, 2 × Mix10 µL, 1 µL cDNA template, and 8 µL H2O. 
Reaction conditions: 95°C 10 min, followed by 30 cycles (94°C 30 s, 
60°C 1 min, 78°C 30 s), and 72°C 5 min. The relative expression of 
miR-597-3p was calculated by 2-∆∆Ct method. The sequence of miR-











miR-597-3p inhibits thyroid carcinoma SW579 cells Hu-Ling Wen et al.
Results
The expression of miR-597-3p and RAB23 
in SW579 cells
In order to detect the role of miR-597-3p in SW579 cell 
invasion and migration, SW579 cells were transfected 
with miR-597-3p mimics. The level of miR-597-3p with 
miR-597-3p mimics group was significantly increased 
compare with the control group and miR-597-3p NC 
group by 1.45 fold and 1.44 fold (Fig. 1A). To analyse 
the changing of RAB23 after transfection, the expression 
of RAB23 was detected, the RAB23 level was decreased 
compared with the control group and miR-597-3p NC 
group by nearly 0.48 fold and 0.49 fold, respectively 
(p < 0.05, Fig. 1B and 1C).
The cell viabilities were decreased in SW579 cells 
after transfection
To evaluate the effect of miR-597-3p on SW579 cell 
viabilities after transfection with miR-597-3p mim-
ics, CCK-8 assay was implemented. From Figure 2A, 
the cell viability of the miR-597-3p mimic group 
was 60.26%, which was lower than the miR-597-3p 
NC group (92.12%) and the control group (90.28%) 
(p < 0.05).
The cell invasion and migration abilities 
were decreased in SW579 cells after transfection
Transwell chamber assay showed that, compared 
with control group and miR-597-3p NC group, the 
miR-597-3p mimic group (miR-597-3p overexpression) 
significantly decreased the invasion and migration 
abilities of SW579 cells (p < 0.05, Fig. 2B and 2C). Fur-
thermore, increasing the level of miR-597-3p signifi-
cantly inhibited the invasion and migration abilities of 
SW579 cells.
The levels of protein invasion and migration 
were decreased in SW579 cells after transfection
To further study of the invasion and migration abilities 
of SW579 cells after transfection with miR-597-3p mimic 
sequences, the proteins of invasion and migration 
were detected. Compared with the control group and 
miR-597-3p NC group, the miR-597-3p mimic group 
had remarkably decreased levels of MMP-2, MMP-9, 
and N-cadherin (p < 0.05), and significantly increased 
levels of E-cadherin (p < 0.05, Fig. 3B and 3C).
RAB23 target of miR-597-3p
To prove RAB23 was the target gene of miR-597-3p, the 
miRTarase Database and Luciferase reporter assay were 
A B
C
Figure 1. The expression of miR-597-3p (A) and RAB23 (B and C) in SW579 cells. Data are expressed as mean ± SD (n = 3). 
*p < 0.05 vs. control group; #p < 0.05 vs. miR-597-3p NC group
25










Figure 2. A. The cell viabilities of SW579 cells after transfection. Data are expressed as mean ± SD (n = 3). B, C. The invasion and 
migration abilities of SW579 cells after transfection. Data are expressed as mean ± SD (n = 3) (×200). *p < 0.05 vs. control group; 
#p < 0.05 vs. miR-597-3p NC group
A B
C
Figure 3. A, B. The level of MMP-2, MMP-9, N-cadherin, and E-cadherin protein in the invasion and migration. Data are expressed 
as mean ± SD (n = 3). *p < 0.05 vs. control group; #p < 0.05 vs. miR-597-3p NC group. C. The suspected binding of miR-597-3p 
with the wild type (WT) 3’UTR region of RAB23 mRNA was shown by the miRTarase Database (www.targetscan.org) (n = 3). 
D. The luciferase activity after miR-597-3p mimics co-transfected with wt-RAB23 3’-UTR or mt-RAB23 3’-UTR. Data are expressed 
as mean ± SD (n = 3). *p < 0.05 vs. transfected with miR-597-3p mimics; #p < 0.05 vs. transfected with miR-597-3p mimics 
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used. The miRTarase Database predicted that the RAB23 
3’-UTR region had three binding points of miR-597-3p 
(Fig. 3C). The Luciferase reporter showed that, notably, 
the luciferase activity of SW579 cells transfected with wt 
RAB23 3’-UTR and miR-597-3p mimics was lower than 
transfected with miR-597-3p mimics only (p < 0.05, 
Fig.  3D). However, luciferase activity of SW579 cells 
showed no significant variation after transfection with 
mt RAB23 3’-UTR (p > 0.05, Fig. 3D).
Discussion
Thyroid carcinoma is a common endocrine tumour. 
Along with the development of medical conditions, the 
therapeutic methods for TC patients have improved in 
most regions of the word, but TC morbidity and mortal-
ity has been continuously increasing in recent decades 
[15, 16]. It has been recently indicated that a relationship 
exists between miRNA and TC; the abnormal expres-
sion of these miRNAs are conducive to the biological 
changes in TC cells [17]. However, the ideal genetic 
marker for TC testing has not yet been discovered, and 
the roles of miR-597-3p in TC remain unclear. Therefore, 
in the current study, we found that overexpression of 
miR-597-3p could down-regulate the expression of 
RAB23, and it decreased the abilities of SW579 cells in 
terms of proliferation, invasion, and migration.
MiRNAs perform a significant function in various 
biological processes of tumour cells by targeting the 
3’-untranslated region and regulating the transla-
tion of their target miRNAs [18]. Several researchers 
have shown that miRNAs can regulate the expression 
of a variety of genes involved in tumour progres-
sion [19]. More and more evidence has shown that 
miRNAs can serve as either tumour suppressors or 
oncogenes in biological processes such as prolifera-
tion, invasion, and migration of tumour cells [20]. 
Wang et al. [21] indicated that miR-338-3p is impli-
cated in prostate cancer and that forced expression 
of miR338-3p suppressed tumour growth in vivo 
as well as proliferation, migration, and invasion in 
vitro. Subsequently, it was shown that miR338-3p 
could bind directly to the 3’-untranslated region of 
RAB23 mRNA and down-regulate the expression of 
RAB23. In addition, Melissa et al. [22] discovered that 
miR-466 was under-expressed in PCa tissue compared 
to normal tissues, and miR-466 suppressed PCa me-
tastasis and growth by directly targeting bone-related 
transcription factor RUNX2. Our study showed that 
the expression of miR-597-3p in SW579 cells was 
significantly increased compared with the control 
group and miR-597-3p NC group by 1.45 fold and 
1.44 fold after transfection with miR-597-3p mimics, 
suggesting that the miR-597-3p mimics were success-
fully transfected in SW579 cells and up-regulated 
miR-597-3p expression. 
The SW579 cell viabilities were measured through 
the CCK-8 assay, and the result showed that the SW579 
cell viabilities sharply decreased and was lower than in 
the miR-597-3p NC group (92.12%) and control group 
(90.28%) after transfection with miR-597-3p mimics, in-
dicating that up-regulation of the expression miR-597-3p 
could suppress the viabilities of SW579 cells. In addi-
tion, the Transwell chamber assay was used to evaluate 
the abilities of invasion and migration of cancer cells; 
the results indicated that the invasion and migration 
abilities of SW579 cells were significantly decreased 
compared with the control group and miR-597-3p NC 
group after transfection with miR-597-3p mimics, indi-
cating that miR-597-3p could regulate the invasion and 
migration abilities of SW579 cells and be involved in 
the progress of TC. Some researchers also illuminated 
the role of miRNAs in TC. The expression of miR-21 
was up-regulated in papillary thyroid carcinoma cells 
and tissues, and then the expression of miR-21 was 
down regulated by PI3K/Akt pathway and invasion 
mediated epithelial-mesenchymal transition (EMT), 
thus inhibiting the proliferation of papillary thyroid 
carcinoma cell [23].The above result different with 
ours study, the different miRNAs may play distinctive 
role in thyroid carcinoma, whereafter, the report found 
that the miR-1280 levels were significantly lower in TC 
cells and tissues compare with healthy thyroid cells 
and adjacent normal tissues, whereas overexpression 
of miR-1280 inhibited cells proliferation and invasion 
of TC cells, besides, overexpression of miR-1280 inhib-
ited ERK and ERa pathway of TC cells [24]. In order to 
deeply explore the effect of the invasion and migration 
of SW579 cells after transfected with miR-597-3p min-
ics, the proteins levels of correlated with invasion and 
migration. The MMPs family is usually found to take 
part in the degradation of extracellular matrix, which 
is involved in cell invasion and migration. MMP-2 and 
MMP-9 are the two most generally researched members 
of this family. Further study indicated that TRIB1-me-
diated invasion and migration of colorectal cancer cells 
requires up-regulation of the expression of MMP-2 by 
activating the ERK and FAK/Src pathway [25]. EGCG 
and IIF are also the most effective treatments in reduc-
ing the expression of marks of migration and invasion 
such as MMP-2, MMP-9, and CD44 in MCF-7, MCF-7 
TAM, and MDA-MB-231 cells [26]. N-cadherin could 
promote the EMT and angiogenesis of tumours, and 
E-cadherin could promote tight junction intercellular 
and inhibit migration of tumour cells. All of these play 
a key role in EMT and are significant in tumour cell 
invasion and migration in various tumour types. The 
research revealed that procollagen-lysine, 2-oxoglutar-
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ate 5-dioxygenase 2 (PLOD2) activated the PI3K/AKT 
signalling pathway and up-regulated the expression 
of EMT regulators such as N-cadherin and vimentin 
and down-regulated the expression of E-cadherin [27]. 
Feng et al. [28] found that down-regulated expression of 
N-cadherin, NF-kB p65, and vimentin and up-regulation 
of E-cadherin decreased the abilities of invasion and 
migration in lung cancer A549 cells. Our study has also 
shown that the overexpression of miR-597-3p decreased 
the abilities of invasion and migration in SW579 cells, 
indicating that up-regulated expression of miR-597-3p 
would decrease the expression of invasion and migra-
tion factors and negatively regulate EMT transcription.
In recent years, the role of RAB23 in malignancy has 
attracted keen interest among researchers. The latest 
reports reveal that RAB23 is significantly up-regulated 
in gastric cell lines, and miR-802 could directly target 
RAB23. Additionally, overexpression of miR-802 sup-
presses the invasion and migration of gastric cell lines 
[29]. In oesophageal squamous cell carcinoma cells the 
expression of RAB23 is up-regulated, and RAB23 knock-
down could inhibit the growth, migration, and invasion, 
suggesting that RAB23 could be a therapeutic target of 
oesophageal squamous cell carcinoma [30]. Meanwhile, 
in hepatocellular carcinoma cells, miR-429 reversed the 
EMT to MET and decreased the migratory capacity 
through targeting of RAB23 [31]. In the present study, 
we found that the expression of RAB23 was up-regulated 
in SW579 cells after transfected with miR-597-3p mim-
ics; subsequently, Luciferase reporter revealed that the 
RAB23 was the target of miR-597-3p in SW579 cells, 
suggesting that miR-597-3p might target-regulate the 
expression of RAB23 and decrease the abilities of prolif-
eration, invasion, and migration in SW579 cells. 
Conclusion
Our study demonstrated that overexpression of 
miR-597-3p could target-regulate the expression of 
RAB23, and might, through that mechanism, decrease 
the expression of MMP-2, MMP-9, and N-cadherin 
and increase the expression of E-cadherin, and then 
suppress the abilities of proliferation, invasion, and 
migration in SW579 cells, suggesting that miR-597-3p 
might become a target gen to cure TC.
Funding 
This study was supported by the Affiliated Hospital of 
North Sichuan Medical College — grant No. 2020ZD015.
References
1. Liu K, Huang W, Yan DQ, et al. Overexpression of long intergenic 
noncoding RNA LINC00312 inhibits the invasion and migration of 
thyroid cancer cells by down-regulating microRNA-197-3p. Biosci Rep. 
2017; 37(4), doi: 10.1042/BSR20170109, indexed in Pubmed: 28539331.
2. Pishkari S, Paryan M, Hashemi M, et al. The role of microRNAs in dif-
ferent types of thyroid carcinoma: a comprehensive analysis to find 
new miRNA supplementary therapies. J Endocrinol Invest. 2018; 41(3): 
269–283, doi: 10.1007/s40618-017-0735-6, indexed in Pubmed: 28762013.
3. Sanabria A, Kowalski LP, Shah JP, et al. Growing incidence of thy-
roid carcinoma in recent years: Factors underlying overdiagno-
sis. Head Neck. 2018; 40(4): 855–866, doi: 10.1002/hed.25029, indexed 
in Pubmed: 29206325.
4. Lin Y, Ma Q, Li L, et al. The CXCL12-CXCR4 axis promotes migration, 
invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP 
cells via NF-kB signaling. Biochem Cell Biol. 2018; 96(5): 619–626, 
doi: 10.1139/bcb-2017-0074, indexed in Pubmed: 29316404.
5. Au JK, Alonso J, Kuan EC, et al. Primary Squamous Cell Carcinoma of the 
Thyroid: A Population-Based Analysis. Otolaryngol Head Neck Surg. 2017; 
157(1): 25–29, doi: 10.1177/0194599817698436, indexed in Pubmed: 28397584.
6. Natalia MA, Alejandro GT, Virginia TVJ, et al. MARK1 is a Novel Target 
for miR-125a-5p: Implications for Cell Migration in Cervical Tumor 
Cells. Microrna. 2018; 7(1): 54–61, doi: 10.2174/221153660666617102416
0244, indexed in Pubmed: 29076440.
7. Li D, Zhang Y, Zhang He, et al. CADM2, as a new target of 
miR-10b, promotes tumor metastasis through FAK/AKT pathway 
in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018; 37(1): 46, 
doi: 10.1186/s13046-018-0699-1, indexed in Pubmed: 29506532.
8. Zheng S, Zhang X, Wang X, et al. Downregulation of miR-138 predicts 
poor prognosis in patients with esophageal squamous cell carcinoma. 
Cancer Biomark. 2017; 20(1): 49–54, doi: 10.3233/CBM-170079, indexed 
in Pubmed: 28759955.
9. Xue KC, Hu DD, Zhao L, et al. MiR-577 inhibits papillary thyroid 
carcinoma cell proliferation, migration and invasion by targeting 
SphK2. Eur Rev Med Pharmacol Sci. 2017; 21(17): 3794–3800, indexed 
in Pubmed: 28975989.
10. Wang WW, Chen B, Lei CB, et al. miR-582-5p inhibits invasion and mi-
gration of salivary adenoid cystic carcinoma cells by targeting FOXC1. 
Jpn J Clin Oncol. 2017; 47(8): 690–698, doi: 10.1093/jjco/hyx073, indexed 
in Pubmed: 28591777.
11. Li Z, Hu Y, Zeng Q, et al. Circular RNA MYLK promotes hepatocellular 
carcinoma progression by increasing Rab23 expression by sponging 
miR-362-3p. Cancer Cell Int. 2019; 19: 211, doi: 10.1186/s12935-019-0926-7, 
indexed in Pubmed: 31413665.
12. Hor CHH, Tang BL, Goh ELK. Rab23 and developmental disor-
ders. Rev Neurosci. 2018; 29(8): 849–860, doi: 10.1515/revneuro-2017-0110, 
indexed in Pubmed: 29727300.
13. Wang Y, Qin H. miR-338-3p targets and suppresses tumorigenicity of 
prostate cancer cells. Am J Cancer Res. 2018; 8(12): 2564–2574, indexed 
in Pubmed: 30662812.
14. Zhang W, Yu F, Wang Yu, et al. Rab23 promotes the cisplatin resistance 
of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway. Oncol 
Lett. 2018; 15(4): 5155–5160, doi:  10.3892/ol.2018.7949, indexed in 
Pubmed: 29552151.
15. Wang CJ, Yang D, Luo YW. Recombinant ING4 suppresses the migration 
of SW579 thyroid cancer cells via epithelial to mesenchymal transition. 
Exp Ther Med. 2015; 10(2): 603–607, doi: 10.3892/etm.2015.2515, indexed 
in Pubmed: 26622361.
16. Kalra R, Pawar R, Hasija S, et al. Frontal bone metastasis from an occult 
follicular thyroid carcinoma: Diagnosed by FNAC. J Cytol. 2017; 34(1): 
59–61, doi: 10.4103/0970-9371.197623, indexed in Pubmed: 28182063.
17. Yuan Q, Liu Y, Fan Y, et al. LncRNA HOTTIP promotes papillary 
thyroid carcinoma cell proliferation, invasion and migration by 
regulating miR-637. Int J Biochem Cell Biol. 2018; 98: 1–9, doi: 10.1016/j.
biocel.2018.02.013, indexed in Pubmed: 29474928.
18. van Beijnum JR, Giovannetti E, Poel D, et al. miRNAs: micro-managers 
of anticancer combination therapies. Angiogenesis. 2017; 20(2): 269–285, 
doi: 10.1007/s10456-017-9545-x, indexed in Pubmed: 28474282.
19. Dong F, Xu T, Shen Y, et al. Dysregulation of miRNAs in bladder cancer: 
altered expression with aberrant biogenesis procedure. Oncotarget. 
2017; 8(16): 27547–27568, doi:  10.18632/oncotarget.15173, indexed in 
Pubmed: 28187437.
20. Adhami M, Haghdoost AA, Sadeghi B, et al. Candidate miRNAs in 
human breast cancer biomarkers: a systematic review. Breast Can-
cer. 2018; 25(2): 198–205, doi:  10.1007/s12282-017-0814-8, indexed in 
Pubmed: 29101635.
21. Wang Y, Qin H. miR-338-3p targets and suppresses tumorigenicity of 
prostate cancer cells. Am J Cancer Res. 2018; 8(12): 2564–2574, indexed 
in Pubmed: 30662812.
22. Colden M, Dar AA, Saini S, et al. MicroRNA-466 inhibits tumor growth 
and bone metastasis in prostate cancer by direct regulation of osteo-
genic transcription factor RUNX2. Cell Death Dis. 2017; 8(1): e2572, 
doi: 10.1038/cddis.2017.15, indexed in Pubmed: 28125091.
23. Zang C, Sun J, Liu W, et al. miRNA-21 promotes cell proliferation and 
invasion via VHL/PI3K/AKT in papillary thyroid carcinoma. Hum 












miR-597-3p inhibits thyroid carcinoma SW579 cells Hu-Ling Wen et al.
24. Meng D, Li Z, Ma X, et al. MicroRNA-1280 modulates cell growth and 
invasion of thyroid carcinoma through targeting estrogen receptor a. 
Cell Mol Biol (Noisy-le-grand). Cell Mol Biol (Noisy-le-grand). 2016; 
62(3): 1–6, indexed in Pubmed: 27064865.
25. Wang Y, Wu N, Pang Bo, et al. TRIB1 promotes colorectal cancer cell 
migration and invasion through activation MMP-2 via FAK/Src and ERK 
pathways. Oncotarget. 2017; 8(29): 47931–47942, doi: 10.18632/oncotar-
get.18201, indexed in Pubmed: 28624785.
26. Farabegoli F, Govoni M, Spisni E, et al. EGFR inhibition by (-)-epi-
gallocatechin-3-gallate and IIF treatments reduces breast cancer cell 
invasion. Biosci Rep. 2017; 37(3), doi: 10.1042/BSR20170168, indexed in 
Pubmed: 28465354.
27. Song Ye, Zheng S, Wang J, et al. Hypoxia-induced PLOD2 promotes 
proliferation, migration and invasion via PI3K/Akt signaling in glioma. 
Oncotarget. 2017; 8(26): 41947–41962, doi:  10.18632/oncotarget.16710, 
indexed in Pubmed: 28410212.
28. Feng H, Lu JJ, Wang Y, et al. Osthole inhibited TGF b-induced epithe-
lial-mesenchymal transition (EMT) by suppressing NF-kB mediated 
Snail activation in lung cancer A549 cells. Cell Adh Migr. 2017; 11(5-6): 
464–475, doi:  10.1080/19336918.2016.1259058, indexed in Pubmed:
28146373.
29. Zhang XY, Mu JH, Liu LY, et al. Upregulation of miR-802 suppresses 
gastric cancer oncogenicity via targeting RAB23 expression. Eur 
Rev Med Pharmacol Sci. 2017; 21(18): 4071–4078, indexed in Pubmed: 
29028094.
30. Cheng L, Yang F, Zhou B, et al. RAB23, regulated by miR-92b, pro-
motes the progression of esophageal squamous cell carcinoma. 
Gene. 2016; 595(1): 31–38, doi:  10.1016/j.gene.2016.09.028, indexed in 
Pubmed: 27659550.
31. Xue H, Tian GY. MiR-429 regulates the metastasis and EMT of HCC 
cells through targeting RAB23. Arch Biochem Biophys. 2018; 637: 48–55, 
doi: 10.1016/j.abb.2017.11.011, indexed in Pubmed: 29191386.
